Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
abandonment, Abbott, accessibility, acquaintance, arthroplasty, Australian, automated, Boaz, breakdown, Capricor, civilian, closest, complimentary, conclusion, contemplated, COO, deal, Deloitte, device, digit, Division, downturn, driven, earlier, ECI, embryonic, ERS, fact, fit, fluctuate, focused, focusing, Forum, Gaza, GM, Hezbollah, hypersensitivity, instrument, IR, Islamist, isometric, KFDA, Korean, KOSDAQ, KRW, lapse, Lebanese, leg, magnitude, Master, militia, missile, mother, motor, moving, needle, notional, NV, outsource, partnership, pathogen, payroll, perspective, pharma, physician, preeclampsia, Privileged, qualification, repair, revert, Rock, scaffold, settle, Shiite, sovereign, Strip, summer, surgical, synthetic, syringe, Telecom, tendon, tenure, Tigenix, true, undergoing, unilaterally, upcoming, vial, VP, winding, women, Won
Removed:
Aldagen, artery, birth, clean, collectively, commencing, consumer, enable, exhibit, expanding, extend, identifiable, inspector, issuable, launch, leasing, Legislation, notice, Omer, OTC, outlined, overallotment, PAD, periodically, placement, prepare, random, real, rental, resale, reserved, standardized, supplement, surgery, termed, vacation, widen
Filing tables
Filing exhibits
- 10-K Annual report
- 10.16 Exhibit 10.16
- 10.17 Exhibit 10.17
- 10.18 Exhibit 10.18
- 10.19 Exhibit 10.19
- 10.20 Exhibit 10.20
- 10.21 Exhibit 10.21
- 10.22 Exhibit 10.22
- 10.23 Exhibit 10.23
- 10.24 Exhibit 10.24
- 10.25 Exhibit 10.25
- 10.26 Exhibit 10.26
- 10.27 Exhibit 10.27
- 10.28 Exhibit 10.28
- 10.29 Exhibit 10.29
- 10.30 Exhibit 10.30
- 23.1 Exhibit 23.1
- 31.1 Exhibit 31.1
- 31.2 Exhibit 31.2
- 32.1 Exhibit 32.1
- 32.2 Exhibit 32.2
- Download Excel data file
- View Excel data file
PLUR similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements on Form S-3 (Registration No. 333-171334, 333-170859, 333-151761, and 333-177009) and in the Registration Statements on Form S-8 (Registration No. 333-173777, 333-162577, 333-111591 and 333-196537) of Pluristem Therapeutics Inc. of our reports dated September 11, 2014, with respect to the consolidated financial statements of Pluristem Therapeutics Inc., and the effectiveness of internal control over financial reporting of Pluristem Therapeutics Inc., included in this Annual Report of Pluristem Therapeutics Inc. (Form 10-K) for the year ended June 30, 2014 filed with the Securities and Exchange Commission.
/s/ Kost Forer Gabbay & Kasierer Kost Forer Gabbay & Kasierer A member of Ernst & Young Global |
Haifa, Israel
September 11, 2014